Skip to content

Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF

Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular Atrial Fibrillation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03061123
Enrollment
91
Registered
2017-02-23
Start date
2015-09-30
Completion date
2017-10-31
Last updated
2023-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Health Literacy

Brief summary

The risk of stroke is markedly elevated in patients with atrial fibrillation (AF). Oral anticoagulation (OAC) is indicated in individuals with moderate and high risk of stroke to the disadvantage of an increased burden from bleeding. Adequate knowledge of this disorder and understanding the benefits and hazards of antithrombotic treatment are essential to incorporate patient´s values and preferences in these decisions. This will further improve acceptance of recommended therapy and augment compliance with OAC. The objective of this investigation is to compare patient´s perceptions and physician´s assessments of benefits and risks of OAC.

Interventions

OTHERQuestionnaire

Sponsors

Medical University of Graz
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed and ECG-documented non-valvular atrial fibrillation * New indication for oral anticoagulation (OAC) * Ability of informed consent

Exclusion criteria

* Existing OAC therapy * Valvular heart disease * History of valve surgery

Design outcomes

Primary

MeasureTime frame
Comparison of subjective stroke risk perception with CHA2DS2-VASc scoreBaseline
Comparison of subjective bleeding risk perception with HAS-BLED scoreBaseline

Secondary

MeasureTime frame
Relationship between accurate perception of stroke and bleeding risks and baseline parameters (highest completed level of education, subjective level of information)Baseline

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026